Single-dose azithromycin for infant growth in Burkina Faso: Prespecified secondary anthropometric outcomes from a randomized controlled trial
ConclusionsSingle-dose azithromycin does not appear to affect weight and height outcomes when administered during early infancy. Trial registrationClinicalTrials.gov NCT03676764
Source: PLoS Medicine - Category: Internal Medicine Authors: Ali Si é Source Type: research
More News: Azithromycin | Burkina Faso Health | Children | Eating Disorders & Weight Management | Internal Medicine | Obesity | Rural Health | Study | Zithromax